Isabelle Debrix
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
Papers in
-
- COVID-19 Clinical Research Studies 6
- Oncology 6
- Neutropenia and Cancer Infections 3
- Bone health and treatments 2
- Co-authors
- Thierry André (4 shared papers)Philippe Colin (1 shared paper)Pascal Piedbois (1 shared paper)N. Tubiana-Mathieu (1 shared paper)Christophe Louvet (1 shared paper)E. Gamelin (1 shared paper)Emmanuel Quinaux (1 shared paper)Olivier Bouché (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)EClinicalMedicine (1 paper)Journal of Chemotherapy (1 paper)Anti-Cancer Drugs (1 paper)The Lancet Respiratory Medicine (1 paper)
- Partner nations
- France
In The Last Decade
Isabelle Debrix
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 66
- Infectious Diseases 741
- Oncology 135
- Urology 39
- Critical Care and Intensive Care Medicine 19
- Rheumatology 40
Countries citing papers authored by Isabelle Debrix
This map shows the geographic impact of Isabelle Debrix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Debrix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Debrix more than expected).
Fields of papers citing papers by Isabelle Debrix
This network shows the impact of papers produced by Isabelle Debrix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Debrix. The network helps show where Isabelle Debrix may publish in the future.
Co-authors
The 25 scholars most cited alongside Isabelle Debrix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 599 | |
| 2 | 2021 | 232 | |
| 3 | 2007 | 123 | |
| 4 | 2010 | 50 | |
| 5 | 2021 | 36 | |
| 6 | Evaluating the differences between fibrin sealants: recommendations from an international advisory panel of hospital pharmacists | 2006 | 28 |
| 7 | 1999 | 24 | |
| 8 | 2013 | 8 | |
| 9 | 2009 | 5 | |
| 10 | 2001 | 4 | |
| 11 | Prescriptions hors AMM en cancérologie : qu'en pensent les experts ? | 2004 | 4 |
| 12 | 2024 | 4 | |
| 13 | 2000 | 3 | |
| 14 | 1999 | 2 | |
| 15 | 2016 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 1999 | 1 | |
| 18 | Évaluation du bon usage des anticancéreux : les limites des indications AMM | 2004 | 1 |
| 19 | 2007 | 1 | |
| 20 | 2009 | 1 |
About Isabelle Debrix
Isabelle Debrix is a scholar working on Infectious Diseases, Oncology, Pharmacology, Pediatrics, Perinatology and Child Health and Health Information Management, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Clinical practice guidelines implementation (3 papers), Pharmaceutical Economics and Policy (3 papers), Pharmaceutical studies and practices (3 papers), Neutropenia and Cancer Infections (3 papers), Bone health and treatments (2 papers), Pharmaceutical industry and healthcare (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Infectious Diseases (741 citations), Oncology (135 citations), Urology (39 citations), Critical Care and Intensive Care Medicine (19 citations) and Rheumatology (40 citations). Isabelle Debrix has collaborated with scholars based in France. Frequent co-authors include Thierry André, Philippe Colin, Pascal Piedbois, N. Tubiana-Mathieu, Christophe Louvet, E. Gamelin, Emmanuel Quinaux, Olivier Bouché, Arnaud Boutan-Laroze and Aimery de Gramont. Their work appears in journals such as Journal of Clinical Oncology, EClinicalMedicine, Journal of Chemotherapy, Anti-Cancer Drugs and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.